γδ T cells unveil their anti-tumor activities by displaying direct cytolytic activities against transformed cells or/and by stimulating or regulating the biological functions of other immune cells, such as DCs, interferon-γ-producing CD8 αβ T cells, and NK cells [27,28,29]. The gene discussed is CD8A; the disease is neoplasm.